Erik Stoops holds a Master Engineering degree in Biochemistry (MSc) from the University of Gent, Belgium and has more than 25 years of experience in the diagnostic industry and has been working on neurodegenerative disorder biomarkers since 2012. Erik has a track record of successfully building and growing innovation-driven diagnostic based companies (Innogenetics, BioMARIC and ADx NeuroSciences). At ADx he led efforts towards development and successful establishment of various body fluid biomarker tests. In his current position he leads the biomarker development programs to support clinical use of the biomarkers and in therapeutic development programs and is member of the core strategic team of the company. In addition he is involved in precompetitive consortia and working groups, was co-PI and PI in grants and contributed to peer reviewed publications on biomarker development, validation and integration into the neurodegeneration field.